Triple

T19773557
Position Surface form Disambiguated ID Type / Status
Subject Allergan E474948 entity
Predicate predecessor P97 FINISHED
Object Actavis plc NE NERFINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Actavis plc | Statement: [Allergan, predecessor, Actavis plc]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Actavis plc
Context triple: [Allergan, predecessor, Actavis plc]
  • A. Mylan
    Mylan is a global generic and specialty pharmaceuticals company known for producing a wide range of affordable medicines and healthcare products.
  • B. Gland Pharma
    Gland Pharma is an Indian pharmaceutical company specializing in injectable formulations and contract manufacturing for global markets.
  • C. Shire plc
    Shire plc was a global biopharmaceutical company, originally based in the UK and later acquired by Takeda, known for developing treatments for rare diseases and specialty conditions.
  • D. Teva Pharmaceutical Industries
    Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
  • E. Lambert Pharmaceutical Company
    Lambert Pharmaceutical Company was a pharmaceutical firm associated with American aviator and businessman Albert Bond Lambert, known for its role in his early business career.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Actavis plc
Target entity description: Actavis plc was a global specialty pharmaceutical company known for its extensive portfolio of generic and branded drugs before rebranding as Allergan.
  • A. Mylan
    Mylan is a global generic and specialty pharmaceuticals company known for producing a wide range of affordable medicines and healthcare products.
  • B. Gland Pharma
    Gland Pharma is an Indian pharmaceutical company specializing in injectable formulations and contract manufacturing for global markets.
  • C. Shire plc
    Shire plc was a global biopharmaceutical company, originally based in the UK and later acquired by Takeda, known for developing treatments for rare diseases and specialty conditions.
  • D. Teva Pharmaceutical Industries
    Teva Pharmaceutical Industries is a global pharmaceutical company based in Israel, best known as one of the world’s largest manufacturers of generic medicines and a producer of specialty and over-the-counter drugs.
  • E. Lambert Pharmaceutical Company
    Lambert Pharmaceutical Company was a pharmaceutical firm associated with American aviator and businessman Albert Bond Lambert, known for its role in his early business career.
  • F. None of above. chosen

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8e51a43a08190956bc6df13c91a77 completed April 10, 2026, 11:55 a.m.
NER Named-entity recognition batch_69e6535e450c8190a2628245ae0d0bd3 completed April 20, 2026, 4:25 p.m.
Created at: April 10, 2026, 1:48 p.m.